CRISPR pioneer Jennifer Doudna's company Scribe Therapeutics inked a major deal with Prevail Therapeutics potentially worth $1.5 billion to create genetic medicines for neurological and neuromuscular diseases. Scribe CEO ...
Scribe Therapeutics found another partner, this time with Prevail Therapeutics, a subsidiary of Eli Lilly, in a $75 million upfront deal for neuromuscular and neurological diseases.
Unlike Scribe’s ex vivo ...
Collaboration combines Scribe Therapeutics’ novel CRISPR by Design™ approach with Prevail Therapeutics’ deep expertise in developing genetic medicines for neurological disorders towards specified genetic targets
Scribe to receive ...
The times are changing in biopharma.
With the top drugmakers no longer committing most of their resources to the pandemic, biopharma is returning to its roots. But it’s clear the ...
Deep in the bellies of cows are tiny microbes that ferment grass and hay, breaking it down into fatty acids that serve as bovine energy—and into planet-warming methane gas. ...
When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to ...
As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now ...
Ambience Healthcare's new product, AutoScribe, embeds into the electronic medical record and works in real-time. When clinicians use AutoScribe, they speak to their patient as they normally would while ...
We sat down with some of the most curious minds in life sciences and healthcare and invited them to share their thoughts on their careers, the future of health ...
“Why is it in popular culture, if you want to live forever, you are evil and you want to kill babies on the side?” says Martin Borch Jensen.
It’s fast ...
Tech billionaires are funding research to help us live longer and healthier lives, but experts warn of an ethical minefield ahead.
When Nir Barzilai specialised in anti-ageing science 30 years ...
Scientists are great at making mice live longer.
Rapamycin, widely prescribed to prevent organ rejection after a transplant, increases the life expectancy of middle-age mice by as much as 60 ...
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.
“Time is quickly running ...
Launch fueled by syndicate of blue-chip investors co-led by Qiming Venture Partners USA and venBio Partners
Company’s proprietary end-to-end Encompass™ platform designs enhancement-targeting chimeric (ENTAC™) molecules
Founding team ...
BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced positive Phase 1b clinical data ...
A guide to contemporary doomsday scenarios — from the threats you know about to the ones you never think of.
And here we are at the crux of our existential ...
The 2020 Nobel Laureate shares her thoughts on the first decade of CRISPR genome editing, where the technology is heading next, and what it needs to get there.
Last month, Genetic ...
Brightseed Bio 01™ is the first ingredient in Brightseed’s portfolio of bioactives discovered by its artificial intelligence (A.I.) platform Forager®
Formulated to optimize bioactives that support gut health, ...
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
A little over 15 years ago, scientists at Kyoto University in Japan made a remarkable discovery. When they ...
From the philosophers whose moral imagination pushes the boundaries of what is possible to the activists making the world a better and healthier place on the ground, from the ...
Startups are creating diets tailored to patients’ medical needs, betting that specially-designed foods can work as powerful weapons against disease.
Interest among venture capitalists in the medical potential of food ...
Sanofi has teamed up with Scribe Therapeutics to write the next chapter in its natural killer (NK) cell therapy story, paying $25 million upfront and committing to $1 billion ...
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe’s CRISPR ...
The following is an excerpt of The Atlantic opinion editorial by CRISPR co-inventor and Nobel Prize-winner Dr. Jennifer Doudna.
CRISPR is changing the world - but it can do more.
Two ...
CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of viruses called ...
Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with ...
It’s entirely possible, maybe even likely, that during some slow day at the lab early in her career, Jennifer Doudna, in a moment of private ambition, daydreamed about making ...
“CRISPR-by-design” is the idea behind Scribe Therapeutics, a company spun out from Jennifer Doudna’s Nobel-winning lab that’s competing in a closely-tracked field of genome editor companies just starting to ...
Cartography Biosciences, a precision medicine company creating therapeutics guided by the first-ever comprehensive antigen atlas for immuno-oncology targets, launched today with $57 million in initial funding. 8VC led the ...
Gene editing has become one of biotech's hottest areas as the first-in-human results have suggested the technology holds the potential to cure certain diseases with a single treatment.
In 2021, ...
Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the completion of its business combination with Arya Sciences Acquisition Corp III ...
Concert Health has inked two new collaborative care partnerships — one with Benson Hospital, a rural health hospital in Arizona, and another with Women’s Health U.S. (WHUSA), a multi-state ...
In this latest "Bloomberg Studio 1.0," host Emily Chang sits down with CRISPR co-inventor and 2020 Nobel Prize winner, Dr. Jennifer Doudna. They discuss her groundbreaking work on DNA, ...
Imagine being able to change the genes responsible for causing diseases. For Scribe Therapeutics, a gene-editing company that develops genetic medicines, this is no longer a dream but a ...
When Jennifer Doudna won the Nobel Prize for Chemistry last year, there was no black-tie ceremony in Sweden. Because of the pandemic, she picked up the medal in her backyard.
Correspondent ...
TechCrunch has covered Noyo a few times in the last year. The startup builds APIs for the insurance market, a bit like what Plaid set out to do for ...
The Royal Swedish Academy of Sciences has decided to award the 2020 Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method ...
A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a platform designed ...
Three years ago, Jennifer Doudna gathered with two postdocs and a fellow biochemist around a circular table on the second floor of UC Berkeley’s Energy Biosciences building, where they ...
The new coronavirus can leave some patients with signs of heart inflammation and injury months after they get sick with Covid-19, even in cases where their illness wasn’t severe, ...
Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to ...
From the images of cloudy chest scans and gasping patients hooked up to ventilators, we’ve been conditioned to think of Covid-19 as a respiratory disease. But it’s not just about the lungs.
Even from ...
Maybe we should think of Covid-19 as a heart disease.
When SARS-CoV-2 virus was added to human heart cells grown in lab dishes, the long muscle fibers that keep hearts ...
Nearly two years after the birth of the first “CRISPR babies” stunned the world, an international group of experts on Thursday warned such human experimentation — in which the DNA ...
It’s still too soon to try to make genetically edited babies because the science isn’t advanced enough to ensure safety, says an international panel of experts who also mapped ...
These tiny, ancient predators do more than cause pandemics.
Host Kenneth Cukier and science editor Geoff Carr investigate how viruses have shaped the world. Evolutionary biologist David Enard explains how ...
The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer ...
Ask any expectant couple what they hope their baby will be, and one answer is likely to be “healthy.”
But one gene gone awry can imperil a child’s health, causing ...
A new Innovative Genomics Institute study is underway at the University of California, Berkeley to find out whether a saliva test can detect and identify asymptomatic carriers of the ...
With the start of school fast approaching, colleges and universities across the U.S. are rushing to rejigger the higher-education experience for the coronavirus era. Many are seeking ways to ...
California is experiencing a surge in reported cases of COVID-19. Three months into the pandemic tests remain scarce.
Early on, at UC Berkeley, Dr. Jennifer Doudna who co-discovered CRISPR gene editing ...
Increasingly inexpensive genetic sequencing and engineering tools could upend everything from health care to fuel.
Why it matters: This bio revolution could lead to a world that is more sustainable and ...
From the moment the world heard about a novel coronavirus, known now as SARS-CoV-2, causing widespread respiratory illnesses in China, scientists leapt into action.
Academic, government, and industry labs mobilized ...
U.C. Berkeley says by next week their robotics lab should be able to analyze 1,000 novel coronavirus test results in a single day.
This news comes as we continue to ...
The World Health Organization has said that the best way to tackle this virus is to test, test, test. This is a call to action for biochemist and CRISPR ...
A team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the discovery of the gene editing technology called CRISPR, has ...
As doctors around the country scramble to diagnose cases of COVID-19, scientists at the University of California, Berkeley’s Innovative Genomics Institute (IGI) are creating from scratch a diagnostic lab ...
Academic science labs around the U.S. are rapidly gearing up to run coronavirus tests for patients in need. They're drawing resources from across campus: technology, chemicals and a formidable ...
Dr. Sanjay Gupta: If you're confused, you're not alone.
Let me start by saying this: There is currently no proven treatment or cure for the novel coronavirus. But I can ...
